Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients attending stroke prevention clinics and a premature atherosclerosis clinic at University Hospital in London, ON, Canada were recruited to the study. They completed a dietary questionnaire, provided stool samples and had blood drawn to measure plasma levels of metabolites produced by the intestinal bacteria.
Patients were phenotyped by their residual score in linear multiple regression with measured carotid plaque burden as the dependent variable and coronary risk factors were predictors. The residual score essentially represents the distance off the regression line of predicted plaque. They were grouped into three categories: Unexplained atherosclerosis (with more plaque than predicted by risk factors; residual score >2); Explained (the amount of plaque predicted by risk factors, residual score >-2 and <2); and Protected (less plaque than predicted by risk factors, residual score <-2).
DNA was extracted from stool samples in the lab of Dr. Allen-Vercoe at University of Guelph. RNA makeup of the intestinal microbiome was assessed in the lab of Dr. Gregory Gloor at Western. Plasma levels of trimethylamine n-oxide, p-cresylsulfate, hippuric acid, p-cresyl glucuronide, pheny acetyl glutamine and phenyl sulfate were measured by ultra-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry in the lab of Dr. Bradley Urquhart at Western.
Nutrient intake over the past year was calculated at the Harvard School of Public Health from the 131 item self-reported and semi-quantitative Harvard Food Frequency Questionnaire (FFQ).
Estimated glomerular filtration rate was calculated from the Chronic Kidney Disease Epidemiological (CKD-EPI) equations.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Unexplained Atherosclerosis phenotype | Residual score in linear regression >2 |
| |
| Explained Atherosclerosis phenotype | Residual score in linear regression <-2, <2 |
| |
| Protected Atherosclerosis phenotype | Residual score <-2 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Plasma levels of metabolites | Diagnostic Test | plasma levels of metabolites |
|
| Measure | Description | Time Frame |
|---|---|---|
| Plasma levels of metabolites in the three phenotypes | Plasma levels of trimethylamine n-oxide, p-cresylsulfate, hippuric acid, p-cresyl glucuronide, pheny acetyl glutamine and phenyl sulfate | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Bacterial profile of the intestinal microbiome | Amplification and sequencing of 16S rRNA gene variable regions | Day 1 |
| Effect of nutrient intake on plasma levels of metabolites | Nutrient analysis from food frequency questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
male, female
Not provided
as above
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stroke Prevention & Atherosclerosis Research Centre | London | Ontario | N6G 2V4 | Canada |
It will depend on requests.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D050197 | Atherosclerosis |
| ID | Term |
|---|---|
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069196 | Gastrointestinal Microbiome |
| ID | Term |
|---|---|
| D064307 | Microbiota |
| D008827 | Microbiological Phenomena |
| D058448 | Biota |
| D044822 | Biodiversity |
Not provided
Not provided
Not provided
Not provided
Not provided
DNA samples stored
| Dietary questionnaire | Behavioral | Harvard food frequency questionnaire |
|
| Intestinal microbiome | Diagnostic Test | amplification and sequencing of 16S rRNA gene variable regions in stool samples |
|
| Day 1 |
| Effect of renal function on plasma levels of metabolites | eGFR from CKD-EPI equations | Day 1 |
| D017753 |
| Ecosystem |
| D004777 | Environment |
| D055669 | Ecological and Environmental Phenomena |
| D001686 | Biological Phenomena |
| D004778 | Environment and Public Health |